ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 81 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151 | -99.8% | 25 | -99.8% | 0.00% | – |
| Q2 2023 | $90,202 | -64.9% | 11,624 | -74.2% | 0.00% | – |
| Q1 2023 | $257,002 | +12750.1% | 45,088 | +9412.2% | 0.00% | – |
| Q3 2022 | $2,000 | -50.0% | 474 | -50.1% | 0.00% | – |
| Q2 2022 | $4,000 | -87.5% | 950 | -84.0% | 0.00% | – |
| Q1 2022 | $32,000 | -96.4% | 5,942 | -90.3% | 0.00% | – |
| Q4 2021 | $900,000 | +61.9% | 61,233 | +130.6% | 0.00% | – |
| Q3 2021 | $556,000 | -62.8% | 26,553 | -68.5% | 0.00% | -100.0% |
| Q2 2021 | $1,493,000 | -48.1% | 84,429 | -28.1% | 0.00% | 0.0% |
| Q1 2021 | $2,877,000 | +881.9% | 117,437 | +1258.8% | 0.00% | – |
| Q4 2020 | $293,000 | +324.6% | 8,643 | +214.1% | 0.00% | – |
| Q3 2020 | $69,000 | -34.3% | 2,752 | -10.6% | 0.00% | – |
| Q2 2020 | $105,000 | – | 3,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |